McKesson Net Acquisitions/Divestitures 2010-2025 | MCK
McKesson annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- McKesson net acquisitions/divestitures for the quarter ending June 30, 2025 were $-3.355B, a 3827.78% decline year-over-year.
- McKesson net acquisitions/divestitures for the twelve months ending June 30, 2025 were $-3.028B, a 6781.82% increase year-over-year.
- McKesson annual net acquisitions/divestitures for 2025 were $0.155B, a 168.89% decline from 2024.
- McKesson annual net acquisitions/divestitures for 2024 were $-0.225B, a 207.14% decline from 2023.
- McKesson annual net acquisitions/divestitures for 2023 were $0.21B, a 63.29% decline from 2022.
McKesson Annual Net Acquisitions/Divestitures
(Millions of US $) |
| 2025 |
$155 |
| 2024 |
$-225 |
| 2023 |
$210 |
| 2022 |
$572 |
| 2021 |
$365 |
| 2020 |
$-96 |
| 2019 |
$-804 |
| 2018 |
$-2,519 |
| 2017 |
$-4,006 |
| 2016 |
$170 |
| 2015 |
$-155 |
| 2014 |
$-4,537 |
| 2013 |
$-1,873 |
| 2012 |
$-1,051 |
| 2011 |
$-183 |
| 2010 |
$-17 |
| 2009 |
$-295 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$85.757B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
